BioCapitiva secures GBP1m seed investment from Archangels and Scottish Enterprise
Scottish bio-tech company, BioCaptiva, has developed a novel next generation “liquid biopsy” technology device that could revolutionise the early diagnosis and monitoring of difficult to detect cancers. The University of Edinburgh spin-out has raised over GBP1 million in seed funding from Edinburgh-based business angel investment syndicate, Archangels, and Scottish Enterprise,